Blog

Summary Pharmacy deserts continue to be a major healthcare issue in the U.S.  About 48 million Americans currently live in […]

Summary Oncology medicine spending is expected to grow by 75% over the next five years due to certain factors: Growing

Summary The Food and Drug Administration (FDA) approved 18 biosimilars in 2025. February was the busiest month for approvals with

Summary The Food and Drug Administration (FDA) approved 46 novel drugs in 2025, four fewer than the amount approved in

Summary Significant 340B program changes in 2025 were driven by federal and state reforms, with major impacts on how hospitals,

Summary In 2025, PBMs adapted to the rapid growth and changing landscape of GLP-1 therapies with new FDA approvals expanding

Summary Many drug shortages are long-lasting, with the majority carrying over year to year and the average duration exceeding four

Summary Nearly 48 million Americans now live in pharmacy deserts, areas where access to local pharmacies is limited, up from

Summary Health system and health center pharmacies face complex challenges in delivering high-quality care and meeting accreditation, payer, and medication

Summary Copay abandonment occurs when patients do not pick up their prescribed medications with rates increasing sharply as drug costs